Log in
HomeClass Notes1,200,000US530,000

PSYC 210 Lecture Notes - Lecture 22: Sequela, Alprazolam, Benzodiazepine

51 views8 pages
bluemosquito338
30 Apr 2018
School
Emory University
Department
Psychology
Course
PSYC 210
Professor
Michael Treadway

For unlimited access to Class Notes, a Class+ subscription is required.

Treatments for Alzheimer's: (select all that apply)
!"#$%$&'&#('%)(*+,-."'-/'*0(&120#-2$"(
34
!"#$%&'"()*+,'$#-().(&('/(
01
5/&("'$"026,('7)-8-&$"9'2$/(:;&12('0#*"9(;'<,$(&='(>()0$;(='*0&$?$&1='(&04@
A4
2-3&%*()!!42/
51
Neurocognitive Disorders differ from other disorders primarily because:
B*&#-7#1;$-2-91'$;'.(22:0#*)*0&()$C(,
34
01
67(8)'.()$+.()&#<(&8)"+)/,+-"'-(+%/&8).($#"
=1
67(8)'.()$+.()7(.#"':&(
51
John is 72 and has suffered from intermittent anxiety for most of his life. Though
he uses medications infrequently, he has a prescription for Xanax and will take
one occasionally in case of high-anxiety situations. He has been at the same
dose (0.5 mg) since he was in his forties. This is:
>++*?):(3'%/()#")/%;;(/"/)-+)7':#"%'"#+-
=+%&*):()').('/+-':&()'-/@(.)#A)#")@(.(-B")A+.)+,"#+-)0
○
C1
D*,='%(0*6;('&#('%)*$"';(";$&$C(;'&-'%("C-,$*C(7$"(;'*;'$&'*9(;='8*+$"9'&#('
(//(0&$?(',-;('860#'#$9#()
D(.8)/%:/"'-"#'&)/(-/#"#E'"#+-)'/)8+%)';(
○
!(-/#"#9#"8)"+)>C0C)#-7#:#"+.8)-(%.+".'-/$#//#+-)#-3.('/(/)
○
D4
0'*?):(3'%/()"7():.'#- *(F/(-/#"#E(/)"+):(-E+*#'E(,#-(/)'/)#")';(/?)$'<#-;)"7()
(AA(3"#9()*+/()$%37)&+@(.1
=1
=++&?):(3'%/()7();+")7++<(*)%,)@#"7)G'-'H1
51
I9(.9#(@J
5+$'#-/)+A)3+;-#"#+-
K
L('/%.#-;)3+;-#"#+-
K
M'"7+,78/#+&+;8)+A)C&E7(#$(.B/)5#/('/(
K
6.('"$(-")
K
N(%.+,/837+&+;8
O+3%/(*)+-)3+;-#"#9()"(/"#-;)A+.)"7()*("(3"#+-)+A)&(/#+-)+.)+"7(.)/+%.3()+A)
#$,'#.$(-"
K
='-)#-3&%*()#-"(&&#;(-3() "(/"#-;))'-*)'//(//$(-")+A);',/)#-)'37#(9($(-")'-*)
',"#"%*(),+"(-"#'&)
K
P#;7)A+3%/)+-)'//(//$(-")Q3+;-#"#9()+.)#-"(&&#;(-3(K
NI6):#+&+;#3'&):'/#/)+.)-(%.+/3#(-3()+A)'-H#("8R*(,.(//#+-R!=SK
!8$,"+$/)+A)5($(-"#')TN=5U
N(;&#;#:&():(A+.()';()VW)TXFYZ),+,%&'"#+-))'")"7'")';(U
='-)7'9()('.&8)+-/("?):%")#"B/).'.(
○
K
C;()[\)T]\ZU
N+")')$'^+.#"8?):%")#-3.('/(/
○
K
C;()_\)F#-3.('/(/)`Z),(.)8('.K
5!L)3.#"(.#')A+.)E(8("&$*'<FAE@
!#;-#A#3'-")3+;-#"#9()*(3&#-()A.+$),.#+.)&(9(&) +A)A%-3"#+-#-;
5+-B")'&@'8/)7'9()"7#/)#-A+.$'"#+-
○
='-)&++<)'")/37++&).(3+.*/
○
a/%'&&8).(&8#-;)+-),'"#(-")A'$#&8
○
='-)"(/")9(.:'&)A&%(-38)#A)8+%)*+-B")7'9()+"7(.)#-A+.$'"#+-
P#;7)&(9(&) 9+3':)@+.*):(A+.(?)8+%),.+:':&8)@+-B")&+/()"7'")
§
='-)/(().('*#-;)&(9(&):(A+.()(H7#:#"#-;)3+;-#"#9()*(3&#-(
§
○
34
b9#*(-3()A+.)*(3&#-()A+%-*)(#"7(.):8)/(&A).(,+.")+.)*%.#-;)"(/"#-;D4
=+;-#"#9()*(3&#-()#-"(.A(.(/)@#"7)#-*(,(-*(-3()+.)*'#&8)&#9#-;A4
2/)-+"):(""(.)(H,&'#-(*):8)'-+"7(.)*#/+.*(.)E4
G(H6(2*(J)')3+-*#"#+-)@7#37)#/)"7()3+-/(c%(-3()+A)'),.(9#+%/)*#/('/()+.)#-^%.8
=+$$+-)3&#-#3'&) /(c%(&'()A+.)N=5
L++*)*#/"%.:'-3(/)3+$$+-)Q7#;7)&':#&#"8
M.(*#3"':&()3+-/(c%(-3(/);#9(-)&'3<)+A)%-*(./"'-*#-;
○
K
2-3.('/(*)'-H#("8
N+")<-+@#-;)@7'"B/);+#-;)+-
○
bHJ)@#A()'-*)-%./()'.()7'9#-;)'-)'AA'#.):(3'%/()"7(8B.()'&@'8/);+#-;)+AA)
"+;("7(.)'-*)/,('<)c%#("&8
○
K
a-,.(*#3"':&(),(.#+*/)+A)#-"(-/()';#"'"#+-)'-*)A.%/".'"#+-K
M'.'-+#')'-*)*(&%/#+-):(&#(A/)$'8)($(.;(?):%")@#"7+%")*#/+.;'-#E'"#+-)
/8$,"+$/
0.'#-)".#(/)"+)A#&&)#-)"7#-;/)8+%)*+-B")<-+@)"7().('/+-)A+.
○
K
F(6)-0-9"$&$?('E$;-),();
0#+&+;#3'&&8)#-A+.$(*)"(/"/
=7'.'3"(.#E(*):8)<-+@-),'"7+&+;8
N+")&#<()+"7(.)$(-"'&)*#/+.*(.(*)3+9(.(*)
○
K
d7'")#/)-(%.+3+;-#"#+-e)
I-)+$"9'8(8-)1J)@7'"B/);+#-;)+-)'-8"#$()8+%)".8)"+)7+&*)'-)#*(')+-&#-()
@#"7+%")&+/#-;)#"
N(%.+-/)<((,)A#.#-;)#-)')/"('*8).'"()%-"#&)8+%)-+)&+-;(.)-((*)"+)
7+&*)"7'"),#(3()+A)#-A+.$'"#+-)+-&#-(
§
○
3&&("&$-"J0-9"$&$?('0-"&)-2J)"7()':#&#"8)"+)*#.(3")8+%.)$#-*)'-*)"7#-;/)8+%)
37+/()"+)7+&*)#-)@+.<#-;)$($+.8)"+)A+3%/)+-)@7'")8+%)@'-")"+)A+3%/)+-f)
-+"):()*#/".'3"(*)
○
A-9"$&$?('/2(>$%$2$&1J)"7()':#&#"8)"+)',,.+'37)'),.+:&($)#-)')*#AA(.(-")@'8
○
3%;&)*0&')(7)(;("&*&$-"J)"7()':#&#"8)"+).(,.(/(-")#-A+.$'"#+-)#-)-+-F
3+-3.("()@'8/
bHJ)'&;(:.')A+.)-%$(.#3'&)c%'-"#"#(/
§
○
K
!3.((-#-;)"(/"/)Qc%#3<)@'8)"+)/(()#A)N=5)#/)3+$#-;)#-
L+=C
○
L#-#FL(-"'&)!"'"(R!"'"%/)Q'/<):'/#3)"7#-;/)
I.#(-"(*)G]J)C.()8+%)+.#(-"(*):8)"7.((J)@7+)8+%)'.(?)@7(.()8+%)
'.(?)@7'")"#$()'-*)*'"()#")#/
§
='-)A+&&+@):'/#3)3+$$'-*/)Q.'#/()8+%.)7'-*
§
!#$,&()@+.<#-;)$($+.8)Q.(,('")"7(/()"7.(()@+.*/):'3<)"+)$(
§
=+$,.(7(-/#+-)'-*)3'&3%&'"#+-
§
!3+.()+%")+A)]\?)*($(-"#')/7+@/)#-)Y`)+.)&+@(.
§
○
2-*#9#*%'&/)@#"7)')7#;7)2g)&('.-)7+@)"+)"'&<)'.+%-*)"7(#.)*(A#3#"/)#-)
$($+.8)+.)3+;-#"#+-
L'8)-+"):()':&()"+).($($:(.)@7+)"7(8B.()"'&<#-;)"+?):%"):8)$'<#-;)
')-+"():8)-+")<-+@#-;)3'-)/+A"(-)(9(.8"7#-;
='-)A++&)A'$#&8)+.)3&#-#3#'-/h
§
P+@)"+)".8)"+)A+.3()"7(),(./+-)"+).(9('&) 7+@)@(&&)"7(8B.()
A%-3"#+-#-;
§
○
K
d+.<#-;)$($+.8)"'/</
L+.(),'."#3%&'.)/3.((-#-;)Q%*&&()$(; +A)"'/</)"7'")3'-).(9('&)*(A#3#"/)#-)
,'."#3%&'.)3+;-#"#9()*+$'#-/
D'.#("8)+A)@#*(&8)%/(*)"'/</)A+.)3+;-#"#+-)#-)*#AA(.(-")*+$'#-/
§
○
NF:'3<)"'/<
P'9()')"'.;("
§
i+%)7'9()"+).($($:(.)#A)8+%.)"'.;(")+33%..(*)G)-%$:(.):'3<
§
!(()')/(.#(/)+A)&(""(./R/8$:+&/)#-).',#*)/%33(//#+-
§
2A)"'.;(")#/)G?)'-*)8+%)/(()'-)G?)#*(-"#A8)"7()&(""(.).#;7"):(A+.()TXF
:'3<U
§
d7'")@'/)"7()3'.*)Y):(A+.(e)TYF:'3<U
§
○
5#;#")/,'-)Q7+@)$'-8)-%$:(./)3'-)8+%).('*)'&+%*)'-*)7+&*)#-)@+.<#-;)
$($+.8
j((,)-%$:(./)#-)$($+.8)'-*).('*)"7($):'3<
§
○
K
C""(-"#+-R3+;-#"#9()3+-".+&
!"+,)!#;-'&)6'/< T.(/,+-/()#-7#:#"#+-U
M.+3(//J
!(()"7#-;/)A&'/7)+-)"7()/3.((-h
P'9()')"'.;("h
d7(-)"7()"'.;(")',,('./?)8+%),.(//)'):%""+-h
!+$("#$(/?).#;7")'A"(.)"7()"'.;(")',,('./?)')/"+,)/#;-'&)@#&&)
',,('.
h
i+%B9()/((-)"7()"'.;(")'-*)'.().('*8)"+);+?):%")/(()"7()/"+,)
/#;-)'-*)-((*)"+)#-7#:#")
h
§
>(")');+)/#;-'&?);(")/"+,)/#;-'&)@#"7#-)Y\\)$#&&#/(3+-*/?)3'-)%/%'&&8)
#-7#:#")c%#3<&8
N+")3&#3<#-;)Q/%33(//A%&).(/,+-/()#-7#:#"#+-h
§
C/)8+%),%/7)"7()/"+,)/#;-'&)A%."7(.)'-*)A%."7(.)+%"?)8+%);(")')
A.(c%(-38)+A)7+@)@(&&)8+%)3'-)#-7#:#")8+%./(&A
§
2A)/+$(+-().('&&8)3'-B")7'-*&()"7()/"+,)/#;-'&)'-*)+-&8)@7(-)#")#/)
/%,(.)3&+/()#-)"#$(?)"7'")/%;;(/"/),++.).(/,+-/()#-7#:#"#+-
§
○
O&'-<(.)6'/<
M%/7)+-()<(8)"+)#-*#3'"()#A)"7()3(-"(.)'..+@)#A),%/7#-;)"+)"7().#;7"?)
'-*)'-+"7(.)#A)#")#/)"+)"7()&(A"
§
=+-;.%(-"J)kQ kQ kQ kQ kQ
b'/8?)3(-"(.)'..+@)#/)A&'-<(*):8)'):%-37),+#-"#-;)#-)"7()/'$()
*#.(3"#+-
h
§
2-3+-;.%(-"kQ kQ Ql)kQ kQ
C..+@),+#-"/)#-)+"7(.)*#.(3"#+-h
§
N(%".'&)K)K kQ K)K
§
○
!".++,)6'/<
2;-+.()+-(),#(3()+A)#-A+.$'"#+-)'-*)A+3%/)+-)'-+"7(.)
§
d+.*/)-'$#-;)3+&+./),.#-"(*)#-)*#AA(.(-")3+&+./)
§
=+-;.%(-"J)A+3%/)+-)-'$#-;)"7()@+.*)'-*)#;-+.#-;)"7()3+&+.)T-+")
"++)*#AA#3%&"U
i(&&+@)>.((-)0&%()4(* m)i(&&+@)>.((-)0&%()4(*h
§
2-3+-;.%(-"J)-'$()3+&+.)+A)"7()#-<)@7#&()#;-+.#-;)"7()@+.*
i(&&+@)>.((-)0&%()4(* m)>.((-)0&%()4(*)i(&&+@h
§
○
K
=+;-#"#9()A&(H#:#&#"8
d#/3+-/#-)='.*)!+."#-;)6'/<)Td=!6U
!(.#(/)+A)`)3'.*/)"7'")7'9()+:^(3"/)9'.8#-;)#-)/7',(?)3+&+.?)'-*)
-%$:(.
§
O&#,)3'.*/)A.+$)*(3<)'-*)^+:)#/)"+);%(//)@7#37)3'.*)$'"37(/
§
67().%&(/)"7'")8+%B.()$'"37#-;)+-)<((,)37'-;#-;
4%&()A+.)$'"37#-;)#/)3+&+.h
4%&()37'-;(/?)-+)&+-;(.)^%/"),#3<#-;):&%(?)37'-;()%-"#&);(""#-;)
"7()-(H");.+%,).#;7"
h
>+):8)/'$()/7',(?)-%$:(.)+A)/7',(/?)("31h
§
2-)#-*#9#*%'&/)@7+)A'#&)"7#/?)"7(8)7'9()-+),.+:&($)#-#"#'&&8)&('.-#-;)')
.%&(?):%")+-3()"7(8)&('.-)#"?)"7(8)-(9(.)&(");+
j((,)/"#3<#-;)@#"7)+.#;#-'&).%&(h
B();(?()*&$?('())-)'Q3'-B")'33(,")"7'")@7'")@+.<(*)+-3()
#/-B")@+.<#-;)-+@
h
§
○
K
E$;(*;(;'-/'E(8("&$*
5#/('/(/J
C&E7(#$(.B/)5#/('/()TV\F_\ZUK
n(@8)0+*8)5#/('/(K
O.+-"+"($,+.'&)5($(-"#'K
D'/3%&'.)5($(-"#'K
C&E7(#$(.B/)5#/('/()TCSU
=+$$+-)/8$,"+$/
Long%term%memory%loss
5+-B").(3+;-#E()@7(.()8+%)'.(?)@7+)8+%)'.(?)A'$#&8?)("31
§
L'8).("'#-)+@-)&+-;)"(.$)$($+.#(/)A.+$)37#&*7++*R('.&8)&#A(
§
P'9()&+/")&+-;)"(.$?)-+")@+.<#-;)$($+.8
§
○
Difficulty%with%language
n+-;)"(.$)$($+.8)+A)@+.*/
§
○
Disorientation
N+")<-+@#-;)@7(.()8+%)'.(?)@7+)8+%)'.(?),(+,&()'.+%-*)8+%
§
○
Mood%symptoms,%agitation
C-H#("8?),'.'-+#'
§
a-*(./"'-*':&()@7(-)8+%)3'-B").($($:(.)"7#-;/),(+,&()"7#-<)8+%)
+%;7")"+).($($:(.
§
○
K
2-9+&9(/),.+A+%-*)$($+.8)*(A#3#"/K
V\F_\Z),'"#(-"/K
M'"7+&+;8
C;;.(;'"#+-)+A)9'.#+%/),.+"(#-)@'/"(),.+*%3"/)A.+$)(9(.8*'8):.'#-)
,.+3(//(/
N((*)"+):()3&('-(*)+%")T+-()+A)<(8)A%-3"#+-/)+A)/,((37U
§
d7(-)"7#/):.('</)*+@-?)7'9()*(,+/#"#+-)+A)@'/"(),.+*%3"/)#-)
"#//%(/)+A)"7():.'#-
§
○
C):#;)&+//)+A);.'8)$'""(.)"7.+%;7+%")"7()3+."(H
M'.")+A)o#-A&'$F';#-;o)Q')&+")+A)@7'")@()3+-/#*(.)';#-;)#/)')
3+-/(c%(-3()+A)"7()#$$%-()/8/"($
i+%.);%")+9(."#$()/"'."/)"+)-+")@+.<)'/)@(&&)#-)/(,'.'"#-;)
"7#-;/)+%")
h
b9(.8"7#-;)8+%)#-;(/")-((*/)"+):()3'.(A%&&8)$'-';(*?)
,'3<';(*?)'-*)/(-")"+)"7().#;7"),&'3(
h
§
○
=7.+-#3)#-3.('/()#-)#$$%-()'3"#9#"8
2$$%-()/8/"($)#/)*(/#;-(*)"+)A#;7")"7.('"/)'")'&&)3+/"/
§
E-"K&',$('-/'$22"(;;=',$('/)-8'$886"(';1;&(8
0'3"(.#'R9#.%/(/)'.()/(")%,)"+):(),'.'/#"(/)'-*)&#9()+AA)+A)7+/"h
2$$%-()/8/"($)<#&&/)8+%)#-)#"/)'""($,")"+)<#&&)"7()9#.%/h
§
2$$%-()/#;-'&#-;)*8/A%-3"#+-)&('*/)"+):#;),.+:&($/
§
○
N(%.+F#-A&'$$'"#+-
L'.<(.)+A):("'F'$8&+#*),&'c%(/)+.)"'%),.+"(#-)"'-;&(/
d#*(/,.('*)"7.+%;7+%")3+."(Hh
='-)"(/")@#"7)Mb6)#$';#-#-;)"+)"';)').'*#+'3"#9()#/+"+,()"+)')
,.+"(#-)"7'"):#-*/)"+)')"'.;("?)*(3'8)#-*#3'"(/),.(/(-3()+A)
$+&(3%&(
h
§
2$$%-()/8/"($)#/)';;.(//#9()'-*)3'-)#-),'.")+A)"7(),&'c%(/)'-*)
#$$%-()/8/"($).(/,+-/(?)3'-)&('*)"+)@#*(/,.('*)*'$';()"+)"#//%(
§
○
D(&*:*812-$,'72*H6(;'*)('.*1'8-)('7)(;("&'$"'3E
L+/"),.(/(-")#-)A.+-"'&)'-*)$(*#'&R,'.#("'&)3+."(H(/)#-)"7():.'#-B/)
*(A'%&")$+*()-("@+.<
®
N+)$'""(.)@7'")"'/<)8+%)@(.()'/<(*)"+)*+)?)3(."'#-).(;#+-/)@+%&*)
:(3+$()&(//)'3"#9()3+$,'.(*)"+)'").(/"
L(*#'&),.(A.+-"'&)3+."(H)'-*)$(*#'&),'.#("'&):(3+$()&(//)
'3"#9()'/)8+%)/"'."(*)*+#-;)'-8)"'/<
67(/().(;#+-/)@(.()#-9+&9(*)#-)');(-(.'&) /(-/()+A)
'@'.(-(//)'-*)"7#-<#-;)':+%")/"%AA
®
h
d7(-)8+%B.()-+")*+#-;)')"'/<?)8+%B.()^%/")"7#-<#-;)'-*)$#-*)#/)
@'-*(.#-;?)'/)/%,,+."(*):8)"7(/()-("@+.</
N((*)'33(//)"+)&+-;)"(.$)$($+.8)"7'")#-A+.$/)7+@)@()
(H,(.#(-3() "7(),.(/(-"
®
h
5(A'%&")-("@+.<)$',/)3&+/(&8)'/)"+)@7(.():("'F'$8&+#*)
,&'c%(/)/7+@)#-)CS
=7'.'3"(.#/"#3/)+A)CS)($(.;()@7(-)"7(/(),&'c%(/)
'33%$%&'"()#-)"7().(;#+-/)#-9+&9(*)#-)*(A'%&")$+*()
-("@+.<
®
h
®
○
K
P(.#"':#&#"8)'-*)CMIb);(-(
CS)#/)7#;7&8)#-7(.#"':&(
6@#-)/"%*#(/)/%;;(/")"7'")p_Z)+A)CS).#/<)#/);(-("#3
®
○
>dC!)/"%*#(/)7'9()#/+&'"(*)X\);(-(/)(H,&'#-#-;) Y\Z)+A)9'.#'-3()#-)CS
○
C,+&#,+,.+"(#-)b)TCMIbU)#/):8)A'.)"7()/".+-;(/")/#-;&().#/<);(-(
4(;%&'"(/)&#,#*)7+$(+/"'/#/
®
2-):.'#-?)3'-):#-*)"+)7(&,).($+9():("'F'$8&+#*
4#/<)'&&(&() #/)CMIb)(`)'-*)#/)#-)`\Z)+A)CS)3'/(/)TX]1pZ)
A.(c%(-38)+A)"7#/);(-()#-);(-(.'&U
h
®
○
K
O.+-"+"($,+.'&)*($(-"#')TO65U
=+$$+-)/8$,"+$/
Poor%executive%function/inhibitory%control
○
Difficulties%with%language,%word-finding
L+.()@#"7)(H(3%"#9()3+-".+&
§
○
Long-term%memory%often%spared
○
Mood%symptoms,%agitation
○
K
!7'.(),'"7+&+;8)@#"7)C&E7(#$(.B/K
P'/)$+.()(H(3%"#9() A%-3"#+-#-;)*(3&#-()Q%-':&()"+),&'-R+.;'-#E(K
d+.<#-;)$($+.8?)#-7#:#"#+-?)37'-;()#-)#-7#:#"#+-K
='-)A#./")',,('.)'/):'*)^%*;($(-")+.)'),.(A.+-"'&)3+."#3'&)&(/#+-K
='-):()*#AA#3%&")@#"7)#-"(.,(./+-'&).(&'"#+-/7#,/):(3'%/()+A)&'3<)+A)3+-".+&)'-*)
#-3.('/(*)#$,%&/#9#"8
K
M++.),(.A+.$'-3()+-)(H(3%"#9()3+-".+&)"(/"/
5#;#")/,'-?)@+.<#-;)$($+.8)"'/</
○
K
D'/3%&'.)*($(-"#'
a/%'&&8)3+-/(c%(-3()+A)')/".+<(K
M.(/(-"'"#+-)+A)/8$,"+$/)'.():'/(*)+-)&+3'"#+-)+A)/".+<()'-*)/%:/(c%(-")
*'$';(
K
L)(*&8("&
>+'&J)(H"(-*),(.#+*)+A)"#$()"7'")8+%B.()A%-3"#+-#-;)@(&&):(3'%/()#")3'-B"):()
/"+,,(*
K
=7+&#-(/"(.'/()#-7#:#"+./)T(HJ)C.#3(,"U
C3("8&37+&#-()P(&,)$'#-"'#-)(H3#"'"+.8)"+-(/
C/)8+%)&+/()'3("8&37+&#-(?)"7#/)A%-3"#+-'&&8)&('*/)"+)@#*(/,.('*)
,.+:&($/
§
○
5.%;)#/)(-E8$()"7'"):.('</)*+@-)'3("8&37+&#-(
○
5#/('/()@#&&),.+;.(//?):%")/&+@(.
○
K
b'.&8)*("(3"#+-R,.(9(-"#+-
67(.()#/)-+.$'&)';#-;
○
n++<)A+.)37'-;()#-)A%-3"#+-).(&'"#9()"+)$#*&#A()
n+/()<(8/)#-)$#*&#A(?)(H,(3"(*) "+)7',,(-)&'"(.)#-)&#A(
§
5+-B")&+/()<(8/)#-)$#*&#A(?)/"'.")&+/#-;)"7($?)3+%&*):()')/#;-
§
○
K
=+;-#"#9(?)'3"#9#"8?)(H(.3#/(?)/+3#'&)(-;';($(-"
0%")3'-)/&+@)"7(),.+;.(//#+-)+A)/8$,"+$/
L'8);(")$+.()"#$()+A):(""(.)A%-3"#+-#-;
§
5+(/)-+")/"+,)*#/('/()A.+$),.+;.(//#-;
§
○
K
Neurocognitive,Disorders
67%./*'8?) C,.#&)XY?)Y\X[
XXJY_)CL
Unlock document

This preview shows pages 1-3 of the document.
Unlock all 8 pages and 3 million more documents.

Already have an account? Log in
Treatments for Alzheimer's: (select all that apply)
!"#$%$&'&#('%)(*+,-."'-/'*0(&120#-2$"(34
!"#$%&'"()*+,'$#-().(&('/(01
5/&("'$"026,('7)-8-&$"9'2$/(:;&12('0#*"9(;'<,$(&='(>()0$;(='*0&$?$&1='(&04@A4
2-3&%*()!!42/51
Neurocognitive Disorders differ from other disorders primarily because:
B*&#-7#1;$-2-91'$;'.(22:0#*)*0&()$C(,34
67(8)7'9()'):(""(.),.+;-+/#/01
67(8)'.()$+.()&#<(&8)"+)/,+-"'-(+%/&8).($#"=1
67(8)'.()$+.()7(.#"':&(51
John is 72 and has suffered from intermittent anxiety for most of his life. Though
he uses medications infrequently, he has a prescription for Xanax and will take
one occasionally in case of high-anxiety situations. He has been at the same
dose (0.5 mg) since he was in his forties. This is:
>++*?):(3'%/()#")/%;;(/"/)-+)7':#"%'"#+-
=+%&*):()').('/+-':&()'-/@(.)#A)#")@(.(-B")A+.)+,"#+-)0
○
C1
D*,='%(0*6;('&#('%)*$"';(";$&$C(;'&-'%("C-,$*C(7$"(;'*;'$&'*9(;='8*+$"9'&#('
(//(0&$?(',-;('860#'#$9#()
D(.8)/%:/"'-"#'&)/(-/#"#E'"#+-)'/)8+%)';(
○
!(-/#"#9#"8)"+)>C0C)#-7#:#"+.8)-(%.+".'-/$#//#+-)#-3.('/(/)
○
D4
0'*?):(3'%/()"7():.'#- *(F/(-/#"#E(/)"+):(-E+*#'E(,#-(/)'/)#")';(/?)$'<#-;)"7()
(AA(3"#9()*+/()$%37)&+@(.1
=1
=++&?):(3'%/()7();+")7++<(*)%,)@#"7)G'-'H151
I9(.9#(@J
5+$'#-/)+A)3+;-#"#+-K
L('/%.#-;)3+;-#"#+-K
M'"7+,78/#+&+;8)+A)C&E7(#$(.B/)5#/('/(K
6.('"$(-")K
N(%.+,/837+&+;8
O+3%/(*)+-)3+;-#"#9()"(/"#-;)A+.)"7()*("(3"#+-)+A)&(/#+-)+.)+"7(.)/+%.3()+A)
#$,'#.$(-"
K
='-)#-3&%*()#-"(&&#;(-3() "(/"#-;))'-*)'//(//$(-")+A);',/)#-)'37#(9($(-")'-*)
',"#"%*(),+"(-"#'&)
K
P#;7)A+3%/)+-)'//(//$(-")Q3+;-#"#9()+.)#-"(&&#;(-3(
K
NI6):#+&+;#3'&):'/#/)+.)-(%.+/3#(-3()+A)'-H#("8R*(,.(//#+-R!=S
K
!8$,"+$/)+A)5($(-"#')TN=5U
N(;&#;#:&():(A+.()';()VW)TXFYZ),+,%&'"#+-))'")"7'")';(U
='-)7'9()('.&8)+-/("?):%")#"B/).'.(
○
K
C;()[\)T]\ZU
N+")')$'^+.#"8?):%")#-3.('/(/
○
K
C;()_\)F#-3.('/(/)`Z),(.)8('.
K
5!L)3.#"(.#')A+.)E(8("&$*'<FAE@
!#;-#A#3'-")3+;-#"#9()*(3&#-()A.+$),.#+.)&(9(&) +A)A%-3"#+-#-;
5+-B")'&@'8/)7'9()"7#/)#-A+.$'"#+-
○
='-)&++<)'")/37++&).(3+.*/
○
a/%'&&8).(&8#-;)+-),'"#(-")A'$#&8
○
='-)"(/")9(.:'&)A&%(-38)#A)8+%)*+-B")7'9()+"7(.)#-A+.$'"#+-
P#;7)&(9(&) 9+3':)@+.*):(A+.(?)8+%),.+:':&8)@+-B")&+/()"7'")
§
='-)/(().('*#-;)&(9(&):(A+.()(H7#:#"#-;)3+;-#"#9()*(3&#-(
§
○
34
b9#*(-3()A+.)*(3&#-()A+%-*)(#"7(.):8)/(&A).(,+.")+.)*%.#-;)"(/"#-;
D4
=+;-#"#9()*(3&#-()#-"(.A(.(/)@#"7)#-*(,(-*(-3()+.)*'#&8)&#9#-;
A4
2/)-+"):(""(.)(H,&'#-(*):8)'-+"7(.)*#/+.*(.)
E4
G(H6(2*(J)')3+-*#"#+-)@7#37)#/)"7()3+-/(c%(-3()+A)'),.(9#+%/)*#/('/()+.)#-^%.8
=+$$+-)3&#-#3'&) /(c%(&'()A+.)N=5
L++*)*#/"%.:'-3(/)3+$$+-)Q7#;7)&':#&#"8
M.(*#3"':&()3+-/(c%(-3(/);#9(-)&'3<)+A)%-*(./"'-*#-;
○
K
2-3.('/(*)'-H#("8
N+")<-+@#-;)@7'"B/);+#-;)+-
○
bHJ)@#A()'-*)-%./()'.()7'9#-;)'-)'AA'#.):(3'%/()"7(8B.()'&@'8/);+#-;)+AA)
"+;("7(.)'-*)/,('<)c%#("&8
○
K
a-,.(*#3"':&(),(.#+*/)+A)#-"(-/()';#"'"#+-)'-*)A.%/".'"#+-
K
M'.'-+#')'-*)*(&%/#+-):(&#(A/)$'8)($(.;(?):%")@#"7+%")*#/+.;'-#E'"#+-)
/8$,"+$/
0.'#-)".#(/)"+)A#&&)#-)"7#-;/)8+%)*+-B")<-+@)"7().('/+-)A+.
○
K
F(6)-0-9"$&$?('E$;-),();
0#+&+;#3'&&8)#-A+.$(*)"(/"/
=7'.'3"(.#E(*):8)<-+@-),'"7+&+;8
N+")&#<()+"7(.)$(-"'&)*#/+.*(.(*)3+9(.(*)
○
K
d7'")#/)-(%.+3+;-#"#+-e)
I-)+$"9'8(8-)1J)@7'"B/);+#-;)+-)'-8"#$()8+%)".8)"+)7+&*)'-)#*(')+-&#-()
@#"7+%")&+/#-;)#"
N(%.+-/)<((,)A#.#-;)#-)')/"('*8).'"()%-"#&)8+%)-+)&+-;(.)-((*)"+)
7+&*)"7'"),#(3()+A)#-A+.$'"#+-)+-&#-(
§
○
3&&("&$-"J0-9"$&$?('0-"&)-2J)"7()':#&#"8)"+)*#.(3")8+%.)$#-*)'-*)"7#-;/)8+%)
37+/()"+)7+&*)#-)@+.<#-;)$($+.8)"+)A+3%/)+-)@7'")8+%)@'-")"+)A+3%/)+-f)
-+"):()*#/".'3"(*)
○
A-9"$&$?('/2(>$%$2$&1J)"7()':#&#"8)"+)',,.+'37)'),.+:&($)#-)')*#AA(.(-")@'8
○
3%;&)*0&')(7)(;("&*&$-"J)"7()':#&#"8)"+).(,.(/(-")#-A+.$'"#+-)#-)-+-F
3+-3.("()@'8/
bHJ)'&;(:.')A+.)-%$(.#3'&)c%'-"#"#(/
§
○
K
!3.((-#-;)"(/"/)Qc%#3<)@'8)"+)/(()#A)N=5)#/)3+$#-;)#-
L+=C
○
L#-#FL(-"'&)!"'"(R!"'"%/)Q'/<):'/#3)"7#-;/)
I.#(-"(*)G]J)C.()8+%)+.#(-"(*):8)"7.((J)@7+)8+%)'.(?)@7(.()8+%)
'.(?)@7'")"#$()'-*)*'"()#")#/
§
='-)A+&&+@):'/#3)3+$$'-*/)Q.'#/()8+%.)7'-*
§
!#$,&()@+.<#-;)$($+.8)Q.(,('")"7(/()"7.(()@+.*/):'3<)"+)$(
§
=+$,.(7(-/#+-)'-*)3'&3%&'"#+-
§
!3+.()+%")+A)]\?)*($(-"#')/7+@/)#-)Y`)+.)&+@(.
§
○
2-*#9#*%'&/)@#"7)')7#;7)2g)&('.-)7+@)"+)"'&<)'.+%-*)"7(#.)*(A#3#"/)#-)
$($+.8)+.)3+;-#"#+-
L'8)-+"):()':&()"+).($($:(.)@7+)"7(8B.()"'&<#-;)"+?):%"):8)$'<#-;)
')-+"():8)-+")<-+@#-;)3'-)/+A"(-)(9(.8"7#-;
='-)A++&)A'$#&8)+.)3&#-#3#'-/h
§
P+@)"+)".8)"+)A+.3()"7(),(./+-)"+).(9('&) 7+@)@(&&)"7(8B.()
A%-3"#+-#-;
§
○
K
d+.<#-;)$($+.8)"'/</
L+.(),'."#3%&'.)/3.((-#-;)Q%*&&()$(; +A)"'/</)"7'")3'-).(9('&)*(A#3#"/)#-)
,'."#3%&'.)3+;-#"#9()*+$'#-/
D'.#("8)+A)@#*(&8)%/(*)"'/</)A+.)3+;-#"#+-)#-)*#AA(.(-")*+$'#-/
§
○
NF:'3<)"'/<
P'9()')"'.;("
§
i+%)7'9()"+).($($:(.)#A)8+%.)"'.;(")+33%..(*)G)-%$:(.):'3<
§
!(()')/(.#(/)+A)&(""(./R/8$:+&/)#-).',#*)/%33(//#+-
§
2A)"'.;(")#/)G?)'-*)8+%)/(()'-)G?)#*(-"#A8)"7()&(""(.).#;7"):(A+.()TXF
:'3<U
§
d7'")@'/)"7()3'.*)Y):(A+.(e)TYF:'3<U
§
○
5#;#")/,'-)Q7+@)$'-8)-%$:(./)3'-)8+%).('*)'&+%*)'-*)7+&*)#-)@+.<#-;)
$($+.8
j((,)-%$:(./)#-)$($+.8)'-*).('*)"7($):'3<
§
○
K
C""(-"#+-R3+;-#"#9()3+-".+&
!"+,)!#;-'&)6'/< T.(/,+-/()#-7#:#"#+-U
M.+3(//J
!(()"7#-;/)A&'/7)+-)"7()/3.((-h
P'9()')"'.;("h
d7(-)"7()"'.;(")',,('./?)8+%),.(//)'):%""+-h
!+$("#$(/?).#;7")'A"(.)"7()"'.;(")',,('./?)')/"+,)/#;-'&)@#&&)
',,('.
h
i+%B9()/((-)"7()"'.;(")'-*)'.().('*8)"+);+?):%")/(()"7()/"+,)
/#;-)'-*)-((*)"+)#-7#:#")
h
§
>(")');+)/#;-'&?);(")/"+,)/#;-'&)@#"7#-)Y\\)$#&&#/(3+-*/?)3'-)%/%'&&8)
#-7#:#")c%#3<&8
N+")3&#3<#-;)Q/%33(//A%&).(/,+-/()#-7#:#"#+-h
§
C/)8+%),%/7)"7()/"+,)/#;-'&)A%."7(.)'-*)A%."7(.)+%"?)8+%);(")')
A.(c%(-38)+A)7+@)@(&&)8+%)3'-)#-7#:#")8+%./(&A
§
2A)/+$(+-().('&&8)3'-B")7'-*&()"7()/"+,)/#;-'&)'-*)+-&8)@7(-)#")#/)
/%,(.)3&+/()#-)"#$(?)"7'")/%;;(/"/),++.).(/,+-/()#-7#:#"#+-
§
○
O&'-<(.)6'/<
M%/7)+-()<(8)"+)#-*#3'"()#A)"7()3(-"(.)'..+@)#A),%/7#-;)"+)"7().#;7"?)
'-*)'-+"7(.)#A)#")#/)"+)"7()&(A"
§
=+-;.%(-"J)kQ kQ kQ kQ kQ
b'/8?)3(-"(.)'..+@)#/)A&'-<(*):8)'):%-37),+#-"#-;)#-)"7()/'$()
*#.(3"#+-
h
§
2-3+-;.%(-"kQ kQ Ql)kQ kQ
C..+@),+#-"/)#-)+"7(.)*#.(3"#+-h
§
N(%".'&)K)K kQ K)K
§
○
!".++,)6'/<
2;-+.()+-(),#(3()+A)#-A+.$'"#+-)'-*)A+3%/)+-)'-+"7(.)
§
d+.*/)-'$#-;)3+&+./),.#-"(*)#-)*#AA(.(-")3+&+./)
§
=+-;.%(-"J)A+3%/)+-)-'$#-;)"7()@+.*)'-*)#;-+.#-;)"7()3+&+.)T-+")
"++)*#AA#3%&"U
i(&&+@)>.((-)0&%()4(* m)i(&&+@)>.((-)0&%()4(*h
§
2-3+-;.%(-"J)-'$()3+&+.)+A)"7()#-<)@7#&()#;-+.#-;)"7()@+.*
i(&&+@)>.((-)0&%()4(* m)>.((-)0&%()4(*)i(&&+@h
§
○
K
=+;-#"#9()A&(H#:#&#"8
d#/3+-/#-)='.*)!+."#-;)6'/<)Td=!6U
!(.#(/)+A)`)3'.*/)"7'")7'9()+:^(3"/)9'.8#-;)#-)/7',(?)3+&+.?)'-*)
-%$:(.
§
O&#,)3'.*/)A.+$)*(3<)'-*)^+:)#/)"+);%(//)@7#37)3'.*)$'"37(/
§
67().%&(/)"7'")8+%B.()$'"37#-;)+-)<((,)37'-;#-;
4%&()A+.)$'"37#-;)#/)3+&+.h
4%&()37'-;(/?)-+)&+-;(.)^%/"),#3<#-;):&%(?)37'-;()%-"#&);(""#-;)
"7()-(H");.+%,).#;7"
h
>+):8)/'$()/7',(?)-%$:(.)+A)/7',(/?)("31h
§
2-)#-*#9#*%'&/)@7+)A'#&)"7#/?)"7(8)7'9()-+),.+:&($)#-#"#'&&8)&('.-#-;)')
.%&(?):%")+-3()"7(8)&('.-)#"?)"7(8)-(9(.)&(");+
j((,)/"#3<#-;)@#"7)+.#;#-'&).%&(h
B();(?()*&$?('())-)'Q3'-B")'33(,")"7'")@7'")@+.<(*)+-3()
#/-B")@+.<#-;)-+@
h
§
○
K
E$;(*;(;'-/'E(8("&$*
5#/('/(/J
C&E7(#$(.B/)5#/('/()TV\F_\ZUK
n(@8)0+*8)5#/('/(K
O.+-"+"($,+.'&)5($(-"#'K
D'/3%&'.)5($(-"#'K
C&E7(#$(.B/)5#/('/()TCSU
=+$$+-)/8$,"+$/
Long%term%memory%loss
5+-B").(3+;-#E()@7(.()8+%)'.(?)@7+)8+%)'.(?)A'$#&8?)("31
§
L'8).("'#-)+@-)&+-;)"(.$)$($+.#(/)A.+$)37#&*7++*R('.&8)&#A(
§
P'9()&+/")&+-;)"(.$?)-+")@+.<#-;)$($+.8
§
○
Difficulty%with%language
n+-;)"(.$)$($+.8)+A)@+.*/
§
○
Disorientation
N+")<-+@#-;)@7(.()8+%)'.(?)@7+)8+%)'.(?),(+,&()'.+%-*)8+%
§
○
Mood%symptoms,%agitation
C-H#("8?),'.'-+#'
§
a-*(./"'-*':&()@7(-)8+%)3'-B").($($:(.)"7#-;/),(+,&()"7#-<)8+%)
+%;7")"+).($($:(.
§
○
K
2-9+&9(/),.+A+%-*)$($+.8)*(A#3#"/K
V\F_\Z),'"#(-"/K
M'"7+&+;8
C;;.(;'"#+-)+A)9'.#+%/),.+"(#-)@'/"(),.+*%3"/)A.+$)(9(.8*'8):.'#-)
,.+3(//(/
N((*)"+):()3&('-(*)+%")T+-()+A)<(8)A%-3"#+-/)+A)/,((37U
§
d7(-)"7#/):.('</)*+@-?)7'9()*(,+/#"#+-)+A)@'/"(),.+*%3"/)#-)
"#//%(/)+A)"7():.'#-
§
○
C):#;)&+//)+A);.'8)$'""(.)"7.+%;7+%")"7()3+."(H
M'.")+A)o#-A&'$F';#-;o)Q')&+")+A)@7'")@()3+-/#*(.)';#-;)#/)')
3+-/(c%(-3()+A)"7()#$$%-()/8/"($
i+%.);%")+9(."#$()/"'."/)"+)-+")@+.<)'/)@(&&)#-)/(,'.'"#-;)
"7#-;/)+%")
h
b9(.8"7#-;)8+%)#-;(/")-((*/)"+):()3'.(A%&&8)$'-';(*?)
,'3<';(*?)'-*)/(-")"+)"7().#;7"),&'3(
h
§
○
=7.+-#3)#-3.('/()#-)#$$%-()'3"#9#"8
2$$%-()/8/"($)#/)*(/#;-(*)"+)A#;7")"7.('"/)'")'&&)3+/"/
§
E-"K&',$('-/'$22"(;;=',$('/)-8'$886"(';1;&(8
0'3"(.#'R9#.%/(/)'.()/(")%,)"+):(),'.'/#"(/)'-*)&#9()+AA)+A)7+/"h
2$$%-()/8/"($)<#&&/)8+%)#-)#"/)'""($,")"+)<#&&)"7()9#.%/h
§
2$$%-()/#;-'&#-;)*8/A%-3"#+-)&('*/)"+):#;),.+:&($/
§
○
N(%.+F#-A&'$$'"#+-
L'.<(.)+A):("'F'$8&+#*),&'c%(/)+.)"'%),.+"(#-)"'-;&(/
d#*(/,.('*)"7.+%;7+%")3+."(Hh
='-)"(/")@#"7)Mb6)#$';#-#-;)"+)"';)').'*#+'3"#9()#/+"+,()"+)')
,.+"(#-)"7'"):#-*/)"+)')"'.;("?)*(3'8)#-*#3'"(/),.(/(-3()+A)
$+&(3%&(
h
§
2$$%-()/8/"($)#/)';;.(//#9()'-*)3'-)#-),'.")+A)"7(),&'c%(/)'-*)
#$$%-()/8/"($).(/,+-/(?)3'-)&('*)"+)@#*(/,.('*)*'$';()"+)"#//%(
§
○
D(&*:*812-$,'72*H6(;'*)('.*1'8-)('7)(;("&'$"'3E
L+/"),.(/(-")#-)A.+-"'&)'-*)$(*#'&R,'.#("'&)3+."(H(/)#-)"7():.'#-B/)
*(A'%&")$+*()-("@+.<
®
N+)$'""(.)@7'")"'/<)8+%)@(.()'/<(*)"+)*+)?)3(."'#-).(;#+-/)@+%&*)
:(3+$()&(//)'3"#9()3+$,'.(*)"+)'").(/"
L(*#'&),.(A.+-"'&)3+."(H)'-*)$(*#'&),'.#("'&):(3+$()&(//)
'3"#9()'/)8+%)/"'."(*)*+#-;)'-8)"'/<
67(/().(;#+-/)@(.()#-9+&9(*)#-)');(-(.'&) /(-/()+A)
'@'.(-(//)'-*)"7#-<#-;)':+%")/"%AA
®
h
d7(-)8+%B.()-+")*+#-;)')"'/<?)8+%B.()^%/")"7#-<#-;)'-*)$#-*)#/)
@'-*(.#-;?)'/)/%,,+."(*):8)"7(/()-("@+.</
N((*)'33(//)"+)&+-;)"(.$)$($+.8)"7'")#-A+.$/)7+@)@()
(H,(.#(-3() "7(),.(/(-"
®
h
5(A'%&")-("@+.<)$',/)3&+/(&8)'/)"+)@7(.():("'F'$8&+#*)
,&'c%(/)/7+@)#-)CS
=7'.'3"(.#/"#3/)+A)CS)($(.;()@7(-)"7(/(),&'c%(/)
'33%$%&'"()#-)"7().(;#+-/)#-9+&9(*)#-)*(A'%&")$+*()
-("@+.<
®
h
®
○
K
P(.#"':#&#"8)'-*)CMIb);(-(
CS)#/)7#;7&8)#-7(.#"':&(
6@#-)/"%*#(/)/%;;(/")"7'")p_Z)+A)CS).#/<)#/);(-("#3
®
○
>dC!)/"%*#(/)7'9()#/+&'"(*)X\);(-(/)(H,&'#-#-;) Y\Z)+A)9'.#'-3()#-)CS
○
C,+&#,+,.+"(#-)b)TCMIbU)#/):8)A'.)"7()/".+-;(/")/#-;&().#/<);(-(
4(;%&'"(/)&#,#*)7+$(+/"'/#/
®
2-):.'#-?)3'-):#-*)"+)7(&,).($+9():("'F'$8&+#*
4#/<)'&&(&() #/)CMIb)(`)'-*)#/)#-)`\Z)+A)CS)3'/(/)TX]1pZ)
A.(c%(-38)+A)"7#/);(-()#-);(-(.'&U
h
®
○
K
O.+-"+"($,+.'&)*($(-"#')TO65U
=+$$+-)/8$,"+$/
Poor%executive%function/inhibitory%control
○
Difficulties%with%language,%word-finding
L+.()@#"7)(H(3%"#9()3+-".+&
§
○
Long-term%memory%often%spared
○
Mood%symptoms,%agitation
○
K
!7'.(),'"7+&+;8)@#"7)C&E7(#$(.B/K
P'/)$+.()(H(3%"#9() A%-3"#+-#-;)*(3&#-()Q%-':&()"+),&'-R+.;'-#E(K
d+.<#-;)$($+.8?)#-7#:#"#+-?)37'-;()#-)#-7#:#"#+-K
='-)A#./")',,('.)'/):'*)^%*;($(-")+.)'),.(A.+-"'&)3+."#3'&)&(/#+-K
='-):()*#AA#3%&")@#"7)#-"(.,(./+-'&).(&'"#+-/7#,/):(3'%/()+A)&'3<)+A)3+-".+&)'-*)
#-3.('/(*)#$,%&/#9#"8
K
M++.),(.A+.$'-3()+-)(H(3%"#9()3+-".+&)"(/"/
5#;#")/,'-?)@+.<#-;)$($+.8)"'/</
○
K
D'/3%&'.)*($(-"#'
a/%'&&8)3+-/(c%(-3()+A)')/".+<(K
M.(/(-"'"#+-)+A)/8$,"+$/)'.():'/(*)+-)&+3'"#+-)+A)/".+<()'-*)/%:/(c%(-")
*'$';(
K
L)(*&8("&
>+'&J)(H"(-*),(.#+*)+A)"#$()"7'")8+%B.()A%-3"#+-#-;)@(&&):(3'%/()#")3'-B"):()
/"+,,(*
K
=7+&#-(/"(.'/()#-7#:#"+./)T(HJ)C.#3(,"U
C3("8&37+&#-()P(&,)$'#-"'#-)(H3#"'"+.8)"+-(/
C/)8+%)&+/()'3("8&37+&#-(?)"7#/)A%-3"#+-'&&8)&('*/)"+)@#*(/,.('*)
,.+:&($/
§
○
5.%;)#/)(-E8$()"7'"):.('</)*+@-)'3("8&37+&#-(
○
5#/('/()@#&&),.+;.(//?):%")/&+@(.
○
K
b'.&8)*("(3"#+-R,.(9(-"#+-
67(.()#/)-+.$'&)';#-;
○
n++<)A+.)37'-;()#-)A%-3"#+-).(&'"#9()"+)$#*&#A()
n+/()<(8/)#-)$#*&#A(?)(H,(3"(*) "+)7',,(-)&'"(.)#-)&#A(
§
5+-B")&+/()<(8/)#-)$#*&#A(?)/"'.")&+/#-;)"7($?)3+%&*):()')/#;-
§
○
K
=+;-#"#9(?)'3"#9#"8?)(H(.3#/(?)/+3#'&)(-;';($(-"
0%")3'-)/&+@)"7(),.+;.(//#+-)+A)/8$,"+$/
L'8);(")$+.()"#$()+A):(""(.)A%-3"#+-#-;
§
5+(/)-+")/"+,)*#/('/()A.+$),.+;.(//#-;
§
○
K
Neurocognitive,Disorders
67%./*'8?) C,.#&)XY?)Y\X[ XXJY_)CL
Unlock document

This preview shows pages 1-3 of the document.
Unlock all 8 pages and 3 million more documents.

Already have an account? Log in
Treatments for Alzheimer's: (select all that apply)
!"#$%$&'&#('%)(*+,-."'-/'*0(&120#-2$"(34
!"#$%&'"()*+,'$#-().(&('/(01
5/&("'$"026,('7)-8-&$"9'2$/(:;&12('0#*"9(;'<,$(&='(>()0$;(='*0&$?$&1='(&04@A4
2-3&%*()!!42/51
Neurocognitive Disorders differ from other disorders primarily because:
B*&#-7#1;$-2-91'$;'.(22:0#*)*0&()$C(,34
67(8)7'9()'):(""(.),.+;-+/#/01
67(8)'.()$+.()&#<(&8)"+)/,+-"'-(+%/&8).($#"=1
67(8)'.()$+.()7(.#"':&(51
John is 72 and has suffered from intermittent anxiety for most of his life. Though
he uses medications infrequently, he has a prescription for Xanax and will take
one occasionally in case of high-anxiety situations. He has been at the same
dose (0.5 mg) since he was in his forties. This is:
>++*?):(3'%/()#")/%;;(/"/)-+)7':#"%'"#+-
=+%&*):()').('/+-':&()'-/@(.)#A)#")@(.(-B")A+.)+,"#+-)0
○
C1
D*,='%(0*6;('&#('%)*$"';(";$&$C(;'&-'%("C-,$*C(7$"(;'*;'$&'*9(;='8*+$"9'&#('
(//(0&$?(',-;('860#'#$9#()
D(.8)/%:/"'-"#'&)/(-/#"#E'"#+-)'/)8+%)';(
○
!(-/#"#9#"8)"+)>C0C)#-7#:#"+.8)-(%.+".'-/$#//#+-)#-3.('/(/)
○
D4
0'*?):(3'%/()"7():.'#- *(F/(-/#"#E(/)"+):(-E+*#'E(,#-(/)'/)#")';(/?)$'<#-;)"7()
(AA(3"#9()*+/()$%37)&+@(.1
=1
=++&?):(3'%/()7();+")7++<(*)%,)@#"7)G'-'H151
I9(.9#(@J
5+$'#-/)+A)3+;-#"#+-K
L('/%.#-;)3+;-#"#+-K
M'"7+,78/#+&+;8)+A)C&E7(#$(.B/)5#/('/(K
6.('"$(-")K
N(%.+,/837+&+;8
O+3%/(*)+-)3+;-#"#9()"(/"#-;)A+.)"7()*("(3"#+-)+A)&(/#+-)+.)+"7(.)/+%.3()+A)
#$,'#.$(-"
K
='-)#-3&%*()#-"(&&#;(-3() "(/"#-;))'-*)'//(//$(-")+A);',/)#-)'37#(9($(-")'-*)
',"#"%*(),+"(-"#'&)
K
P#;7)A+3%/)+-)'//(//$(-")Q3+;-#"#9()+.)#-"(&&#;(-3(K
NI6):#+&+;#3'&):'/#/)+.)-(%.+/3#(-3()+A)'-H#("8R*(,.(//#+-R!=SK
!8$,"+$/)+A)5($(-"#')TN=5U
N(;&#;#:&():(A+.()';()VW)TXFYZ),+,%&'"#+-))'")"7'")';(U
='-)7'9()('.&8)+-/("?):%")#"B/).'.(
○
K
C;()[\)T]\ZU
N+")')$'^+.#"8?):%")#-3.('/(/
○
K
C;()_\)F#-3.('/(/)`Z),(.)8('.K
5!L)3.#"(.#')A+.)E(8("&$*'<FAE@
!#;-#A#3'-")3+;-#"#9()*(3&#-()A.+$),.#+.)&(9(&) +A)A%-3"#+-#-;
5+-B")'&@'8/)7'9()"7#/)#-A+.$'"#+-
○
='-)&++<)'")/37++&).(3+.*/
○
a/%'&&8).(&8#-;)+-),'"#(-")A'$#&8
○
='-)"(/")9(.:'&)A&%(-38)#A)8+%)*+-B")7'9()+"7(.)#-A+.$'"#+-
P#;7)&(9(&) 9+3':)@+.*):(A+.(?)8+%),.+:':&8)@+-B")&+/()"7'")
§
='-)/(().('*#-;)&(9(&):(A+.()(H7#:#"#-;)3+;-#"#9()*(3&#-(
§
○
34
b9#*(-3()A+.)*(3&#-()A+%-*)(#"7(.):8)/(&A).(,+.")+.)*%.#-;)"(/"#-;D4
=+;-#"#9()*(3&#-()#-"(.A(.(/)@#"7)#-*(,(-*(-3()+.)*'#&8)&#9#-;A4
2/)-+"):(""(.)(H,&'#-(*):8)'-+"7(.)*#/+.*(.)E4
G(H6(2*(J)')3+-*#"#+-)@7#37)#/)"7()3+-/(c%(-3()+A)'),.(9#+%/)*#/('/()+.)#-^%.8
=+$$+-)3&#-#3'&) /(c%(&'()A+.)N=5
L++*)*#/"%.:'-3(/)3+$$+-)Q7#;7)&':#&#"8
M.(*#3"':&()3+-/(c%(-3(/);#9(-)&'3<)+A)%-*(./"'-*#-;
○
K
2-3.('/(*)'-H#("8
N+")<-+@#-;)@7'"B/);+#-;)+-
○
bHJ)@#A()'-*)-%./()'.()7'9#-;)'-)'AA'#.):(3'%/()"7(8B.()'&@'8/);+#-;)+AA)
"+;("7(.)'-*)/,('<)c%#("&8
○
K
a-,.(*#3"':&(),(.#+*/)+A)#-"(-/()';#"'"#+-)'-*)A.%/".'"#+-K
M'.'-+#')'-*)*(&%/#+-):(&#(A/)$'8)($(.;(?):%")@#"7+%")*#/+.;'-#E'"#+-)
/8$,"+$/
0.'#-)".#(/)"+)A#&&)#-)"7#-;/)8+%)*+-B")<-+@)"7().('/+-)A+.
○
K
F(6)-0-9"$&$?('E$;-),();
0#+&+;#3'&&8)#-A+.$(*)"(/"/
=7'.'3"(.#E(*):8)<-+@-),'"7+&+;8
N+")&#<()+"7(.)$(-"'&)*#/+.*(.(*)3+9(.(*)
○
K
d7'")#/)-(%.+3+;-#"#+-e)
I-)+$"9'8(8-)1J)@7'"B/);+#-;)+-)'-8"#$()8+%)".8)"+)7+&*)'-)#*(')+-&#-()
@#"7+%")&+/#-;)#"
N(%.+-/)<((,)A#.#-;)#-)')/"('*8).'"()%-"#&)8+%)-+)&+-;(.)-((*)"+)
7+&*)"7'"),#(3()+A)#-A+.$'"#+-)+-&#-(
§
○
3&&("&$-"J0-9"$&$?('0-"&)-2J)"7()':#&#"8)"+)*#.(3")8+%.)$#-*)'-*)"7#-;/)8+%)
37+/()"+)7+&*)#-)@+.<#-;)$($+.8)"+)A+3%/)+-)@7'")8+%)@'-")"+)A+3%/)+-f)
-+"):()*#/".'3"(*)
○
A-9"$&$?('/2(>$%$2$&1J)"7()':#&#"8)"+)',,.+'37)'),.+:&($)#-)')*#AA(.(-")@'8
○
3%;&)*0&')(7)(;("&*&$-"J)"7()':#&#"8)"+).(,.(/(-")#-A+.$'"#+-)#-)-+-F
3+-3.("()@'8/
bHJ)'&;(:.')A+.)-%$(.#3'&)c%'-"#"#(/
§
○
K
!3.((-#-;)"(/"/)Qc%#3<)@'8)"+)/(()#A)N=5)#/)3+$#-;)#-
L+=C
○
L#-#FL(-"'&)!"'"(R!"'"%/)Q'/<):'/#3)"7#-;/)
I.#(-"(*)G]J)C.()8+%)+.#(-"(*):8)"7.((J)@7+)8+%)'.(?)@7(.()8+%)
'.(?)@7'")"#$()'-*)*'"()#")#/
§
='-)A+&&+@):'/#3)3+$$'-*/)Q.'#/()8+%.)7'-*
§
!#$,&()@+.<#-;)$($+.8)Q.(,('")"7(/()"7.(()@+.*/):'3<)"+)$(
§
=+$,.(7(-/#+-)'-*)3'&3%&'"#+-
§
!3+.()+%")+A)]\?)*($(-"#')/7+@/)#-)Y`)+.)&+@(.
§
○
2-*#9#*%'&/)@#"7)')7#;7)2g)&('.-)7+@)"+)"'&<)'.+%-*)"7(#.)*(A#3#"/)#-)
$($+.8)+.)3+;-#"#+-
L'8)-+"):()':&()"+).($($:(.)@7+)"7(8B.()"'&<#-;)"+?):%"):8)$'<#-;)
')-+"():8)-+")<-+@#-;)3'-)/+A"(-)(9(.8"7#-;
='-)A++&)A'$#&8)+.)3&#-#3#'-/
h
§
P+@)"+)".8)"+)A+.3()"7(),(./+-)"+).(9('&) 7+@)@(&&)"7(8B.()
A%-3"#+-#-;
§
○
K
d+.<#-;)$($+.8)"'/</
L+.(),'."#3%&'.)/3.((-#-;)Q%*&&()$(; +A)"'/</)"7'")3'-).(9('&)*(A#3#"/)#-)
,'."#3%&'.)3+;-#"#9()*+$'#-/
D'.#("8)+A)@#*(&8)%/(*)"'/</)A+.)3+;-#"#+-)#-)*#AA(.(-")*+$'#-/
§
○
NF:'3<)"'/<
P'9()')"'.;("
§
i+%)7'9()"+).($($:(.)#A)8+%.)"'.;(")+33%..(*)G)-%$:(.):'3<
§
!(()')/(.#(/)+A)&(""(./R/8$:+&/)#-).',#*)/%33(//#+-
§
2A)"'.;(")#/)G?)'-*)8+%)/(()'-)G?)#*(-"#A8)"7()&(""(.).#;7"):(A+.()TXF
:'3<U
§
d7'")@'/)"7()3'.*)Y):(A+.(e)TYF:'3<U
§
○
5#;#")/,'-)Q7+@)$'-8)-%$:(./)3'-)8+%).('*)'&+%*)'-*)7+&*)#-)@+.<#-;)
$($+.8
j((,)-%$:(./)#-)$($+.8)'-*).('*)"7($):'3<
§
○
K
C""(-"#+-R3+;-#"#9()3+-".+&
!"+,)!#;-'&)6'/< T.(/,+-/()#-7#:#"#+-U
M.+3(//J
!(()"7#-;/)A&'/7)+-)"7()/3.((-h
P'9()')"'.;("h
d7(-)"7()"'.;(")',,('./?)8+%),.(//)'):%""+-h
!+$("#$(/?).#;7")'A"(.)"7()"'.;(")',,('./?)')/"+,)/#;-'&)@#&&)
',,('.
h
i+%B9()/((-)"7()"'.;(")'-*)'.().('*8)"+);+?):%")/(()"7()/"+,)
/#;-)'-*)-((*)"+)#-7#:#")
h
§
>(")');+)/#;-'&?);(")/"+,)/#;-'&)@#"7#-)Y\\)$#&&#/(3+-*/?)3'-)%/%'&&8)
#-7#:#")c%#3<&8
N+")3&#3<#-;)Q/%33(//A%&).(/,+-/()#-7#:#"#+-h
§
C/)8+%),%/7)"7()/"+,)/#;-'&)A%."7(.)'-*)A%."7(.)+%"?)8+%);(")')
A.(c%(-38)+A)7+@)@(&&)8+%)3'-)#-7#:#")8+%./(&A
§
2A)/+$(+-().('&&8)3'-B")7'-*&()"7()/"+,)/#;-'&)'-*)+-&8)@7(-)#")#/)
/%,(.)3&+/()#-)"#$(?)"7'")/%;;(/"/),++.).(/,+-/()#-7#:#"#+-
§
○
O&'-<(.)6'/<
M%/7)+-()<(8)"+)#-*#3'"()#A)"7()3(-"(.)'..+@)#A),%/7#-;)"+)"7().#;7"?)
'-*)'-+"7(.)#A)#")#/)"+)"7()&(A"
§
=+-;.%(-"J)kQ kQ kQ kQ kQ
b'/8?)3(-"(.)'..+@)#/)A&'-<(*):8)'):%-37),+#-"#-;)#-)"7()/'$()
*#.(3"#+-
h
§
2-3+-;.%(-"kQ kQ Ql)kQ kQ
C..+@),+#-"/)#-)+"7(.)*#.(3"#+-h
§
N(%".'&)K)K kQ K)K
§
○
!".++,)6'/<
2;-+.()+-(),#(3()+A)#-A+.$'"#+-)'-*)A+3%/)+-)'-+"7(.)
§
d+.*/)-'$#-;)3+&+./),.#-"(*)#-)*#AA(.(-")3+&+./)
§
=+-;.%(-"J)A+3%/)+-)-'$#-;)"7()@+.*)'-*)#;-+.#-;)"7()3+&+.)T-+")
"++)*#AA#3%&"U
i(&&+@)>.((-)0&%()4(* m)i(&&+@)>.((-)0&%()4(*h
§
2-3+-;.%(-"J)-'$()3+&+.)+A)"7()#-<)@7#&()#;-+.#-;)"7()@+.*
i(&&+@)>.((-)0&%()4(* m)>.((-)0&%()4(*)i(&&+@h
§
○
K
=+;-#"#9()A&(H#:#&#"8
d#/3+-/#-)='.*)!+."#-;)6'/<)Td=!6U
!(.#(/)+A)`)3'.*/)"7'")7'9()+:^(3"/)9'.8#-;)#-)/7',(?)3+&+.?)'-*)
-%$:(.
§
O&#,)3'.*/)A.+$)*(3<)'-*)^+:)#/)"+);%(//)@7#37)3'.*)$'"37(/
§
67().%&(/)"7'")8+%B.()$'"37#-;)+-)<((,)37'-;#-;
4%&()A+.)$'"37#-;)#/)3+&+.h
4%&()37'-;(/?)-+)&+-;(.)^%/"),#3<#-;):&%(?)37'-;()%-"#&);(""#-;)
"7()-(H");.+%,).#;7"
h
>+):8)/'$()/7',(?)-%$:(.)+A)/7',(/?)("31h
§
2-)#-*#9#*%'&/)@7+)A'#&)"7#/?)"7(8)7'9()-+),.+:&($)#-#"#'&&8)&('.-#-;)')
.%&(?):%")+-3()"7(8)&('.-)#"?)"7(8)-(9(.)&(");+
j((,)/"#3<#-;)@#"7)+.#;#-'&).%&(h
B();(?()*&$?('())-)'Q3'-B")'33(,")"7'")@7'")@+.<(*)+-3()
#/-B")@+.<#-;)-+@
h
§
○
K
E$;(*;(;'-/'E(8("&$*
5#/('/(/J
C&E7(#$(.B/)5#/('/()TV\F_\ZUK
n(@8)0+*8)5#/('/(K
O.+-"+"($,+.'&)5($(-"#'K
D'/3%&'.)5($(-"#'K
C&E7(#$(.B/)5#/('/()TCSU
=+$$+-)/8$,"+$/
Long%term%memory%loss
5+-B").(3+;-#E()@7(.()8+%)'.(?)@7+)8+%)'.(?)A'$#&8?)("31
§
L'8).("'#-)+@-)&+-;)"(.$)$($+.#(/)A.+$)37#&*7++*R('.&8)&#A(
§
P'9()&+/")&+-;)"(.$?)-+")@+.<#-;)$($+.8
§
○
Difficulty%with%language
n+-;)"(.$)$($+.8)+A)@+.*/
§
○
Disorientation
N+")<-+@#-;)@7(.()8+%)'.(?)@7+)8+%)'.(?),(+,&()'.+%-*)8+%
§
○
Mood%symptoms,%agitation
C-H#("8?),'.'-+#'
§
a-*(./"'-*':&()@7(-)8+%)3'-B").($($:(.)"7#-;/),(+,&()"7#-<)8+%)
+%;7")"+).($($:(.
§
○
K
2-9+&9(/),.+A+%-*)$($+.8)*(A#3#"/K
V\F_\Z),'"#(-"/K
M'"7+&+;8
C;;.(;'"#+-)+A)9'.#+%/),.+"(#-)@'/"(),.+*%3"/)A.+$)(9(.8*'8):.'#-)
,.+3(//(/
N((*)"+):()3&('-(*)+%")T+-()+A)<(8)A%-3"#+-/)+A)/,((37U
§
d7(-)"7#/):.('</)*+@-?)7'9()*(,+/#"#+-)+A)@'/"(),.+*%3"/)#-)
"#//%(/)+A)"7():.'#-
§
○
C):#;)&+//)+A);.'8)$'""(.)"7.+%;7+%")"7()3+."(H
M'.")+A)o#-A&'$F';#-;o)Q')&+")+A)@7'")@()3+-/#*(.)';#-;)#/)')
3+-/(c%(-3()+A)"7()#$$%-()/8/"($
i+%.);%")+9(."#$()/"'."/)"+)-+")@+.<)'/)@(&&)#-)/(,'.'"#-;)
"7#-;/)+%")
h
b9(.8"7#-;)8+%)#-;(/")-((*/)"+):()3'.(A%&&8)$'-';(*?)
,'3<';(*?)'-*)/(-")"+)"7().#;7"),&'3(
h
§
○
=7.+-#3)#-3.('/()#-)#$$%-()'3"#9#"8
2$$%-()/8/"($)#/)*(/#;-(*)"+)A#;7")"7.('"/)'")'&&)3+/"/
§
E-"K&',$('-/'$22"(;;=',$('/)-8'$886"(';1;&(8
0'3"(.#'R9#.%/(/)'.()/(")%,)"+):(),'.'/#"(/)'-*)&#9()+AA)+A)7+/"h
2$$%-()/8/"($)<#&&/)8+%)#-)#"/)'""($,")"+)<#&&)"7()9#.%/h
§
2$$%-()/#;-'&#-;)*8/A%-3"#+-)&('*/)"+):#;),.+:&($/
§
○
N(%.+F#-A&'$$'"#+-
L'.<(.)+A):("'F'$8&+#*),&'c%(/)+.)"'%),.+"(#-)"'-;&(/
d#*(/,.('*)"7.+%;7+%")3+."(Hh
='-)"(/")@#"7)Mb6)#$';#-#-;)"+)"';)').'*#+'3"#9()#/+"+,()"+)')
,.+"(#-)"7'"):#-*/)"+)')"'.;("?)*(3'8)#-*#3'"(/),.(/(-3()+A)
$+&(3%&(
h
§
2$$%-()/8/"($)#/)';;.(//#9()'-*)3'-)#-),'.")+A)"7(),&'c%(/)'-*)
#$$%-()/8/"($).(/,+-/(?)3'-)&('*)"+)@#*(/,.('*)*'$';()"+)"#//%(
§
○
D(&*:*812-$,'72*H6(;'*)('.*1'8-)('7)(;("&'$"'3E
L+/"),.(/(-")#-)A.+-"'&)'-*)$(*#'&R,'.#("'&)3+."(H(/)#-)"7():.'#-B/)
*(A'%&")$+*()-("@+.<
®
N+)$'""(.)@7'")"'/<)8+%)@(.()'/<(*)"+)*+)?)3(."'#-).(;#+-/)@+%&*)
:(3+$()&(//)'3"#9()3+$,'.(*)"+)'").(/"
L(*#'&),.(A.+-"'&)3+."(H)'-*)$(*#'&),'.#("'&):(3+$()&(//)
'3"#9()'/)8+%)/"'."(*)*+#-;)'-8)"'/<
67(/().(;#+-/)@(.()#-9+&9(*)#-)');(-(.'&) /(-/()+A)
'@'.(-(//)'-*)"7#-<#-;)':+%")/"%AA
®
h
d7(-)8+%B.()-+")*+#-;)')"'/<?)8+%B.()^%/")"7#-<#-;)'-*)$#-*)#/)
@'-*(.#-;?)'/)/%,,+."(*):8)"7(/()-("@+.</
N((*)'33(//)"+)&+-;)"(.$)$($+.8)"7'")#-A+.$/)7+@)@()
(H,(.#(-3() "7(),.(/(-"
®
h
5(A'%&")-("@+.<)$',/)3&+/(&8)'/)"+)@7(.():("'F'$8&+#*)
,&'c%(/)/7+@)#-)CS
=7'.'3"(.#/"#3/)+A)CS)($(.;()@7(-)"7(/(),&'c%(/)
'33%$%&'"()#-)"7().(;#+-/)#-9+&9(*)#-)*(A'%&")$+*()
-("@+.<
®
h
®
○
K
P(.#"':#&#"8)'-*)CMIb);(-(
CS)#/)7#;7&8)#-7(.#"':&(
6@#-)/"%*#(/)/%;;(/")"7'")p_Z)+A)CS).#/<)#/);(-("#3
®
○
>dC!)/"%*#(/)7'9()#/+&'"(*)X\);(-(/)(H,&'#-#-;) Y\Z)+A)9'.#'-3()#-)CS
○
C,+&#,+,.+"(#-)b)TCMIbU)#/):8)A'.)"7()/".+-;(/")/#-;&().#/<);(-(
4(;%&'"(/)&#,#*)7+$(+/"'/#/
®
2-):.'#-?)3'-):#-*)"+)7(&,).($+9():("'F'$8&+#*
4#/<)'&&(&() #/)CMIb)(`)'-*)#/)#-)`\Z)+A)CS)3'/(/)TX]1pZ)
A.(c%(-38)+A)"7#/);(-()#-);(-(.'&U
h
®
○
K
O.+-"+"($,+.'&)*($(-"#')TO65U
=+$$+-)/8$,"+$/
Poor%executive%function/inhibitory%control
○
Difficulties%with%language,%word-finding
L+.()@#"7)(H(3%"#9()3+-".+&
§
○
Long-term%memory%often%spared
○
Mood%symptoms,%agitation
○
K
!7'.(),'"7+&+;8)@#"7)C&E7(#$(.B/K
P'/)$+.()(H(3%"#9() A%-3"#+-#-;)*(3&#-()Q%-':&()"+),&'-R+.;'-#E(K
d+.<#-;)$($+.8?)#-7#:#"#+-?)37'-;()#-)#-7#:#"#+-K
='-)A#./")',,('.)'/):'*)^%*;($(-")+.)'),.(A.+-"'&)3+."#3'&)&(/#+-K
='-):()*#AA#3%&")@#"7)#-"(.,(./+-'&).(&'"#+-/7#,/):(3'%/()+A)&'3<)+A)3+-".+&)'-*)
#-3.('/(*)#$,%&/#9#"8
K
M++.),(.A+.$'-3()+-)(H(3%"#9()3+-".+&)"(/"/
5#;#")/,'-?)@+.<#-;)$($+.8)"'/</
○
K
D'/3%&'.)*($(-"#'
a/%'&&8)3+-/(c%(-3()+A)')/".+<(K
M.(/(-"'"#+-)+A)/8$,"+$/)'.():'/(*)+-)&+3'"#+-)+A)/".+<()'-*)/%:/(c%(-")
*'$';(
K
L)(*&8("&
>+'&J)(H"(-*),(.#+*)+A)"#$()"7'")8+%B.()A%-3"#+-#-;)@(&&):(3'%/()#")3'-B"):()
/"+,,(*
K
=7+&#-(/"(.'/()#-7#:#"+./)T(HJ)C.#3(,"U
C3("8&37+&#-()P(&,)$'#-"'#-)(H3#"'"+.8)"+-(/
C/)8+%)&+/()'3("8&37+&#-(?)"7#/)A%-3"#+-'&&8)&('*/)"+)@#*(/,.('*)
,.+:&($/
§
○
5.%;)#/)(-E8$()"7'"):.('</)*+@-)'3("8&37+&#-(
○
5#/('/()@#&&),.+;.(//?):%")/&+@(.
○
K
b'.&8)*("(3"#+-R,.(9(-"#+-
67(.()#/)-+.$'&)';#-;
○
n++<)A+.)37'-;()#-)A%-3"#+-).(&'"#9()"+)$#*&#A()
n+/()<(8/)#-)$#*&#A(?)(H,(3"(*) "+)7',,(-)&'"(.)#-)&#A(
§
5+-B")&+/()<(8/)#-)$#*&#A(?)/"'.")&+/#-;)"7($?)3+%&*):()')/#;-
§
○
K
=+;-#"#9(?)'3"#9#"8?)(H(.3#/(?)/+3#'&)(-;';($(-"
0%")3'-)/&+@)"7(),.+;.(//#+-)+A)/8$,"+$/
L'8);(")$+.()"#$()+A):(""(.)A%-3"#+-#-;
§
5+(/)-+")/"+,)*#/('/()A.+$),.+;.(//#-;
§
○
K
Neurocognitive,Disorders
67%./*'8?) C,.#&)XY?)Y\X[ XXJY_)CL
Unlock document

This preview shows pages 1-3 of the document.
Unlock all 8 pages and 3 million more documents.

Already have an account? Log in

Document Summary

Often include promoting life-style changes (diet, exercise, activity, etc. ) Neurocognitive disorders differ from other disorders primarily because: John is 72 and has suffered from intermittent anxiety for most of his life. Though he uses medications infrequently, he has a prescription for xanax and will take one occasionally in case of high-anxiety situations. He has been at the same dose (0. 5 mg) since he was in his forties. Could be a reasonable answer if it weren"t for option b. Bad, because the brain sensitizes to benzodiazepines as it ages, making the effective dose much higher. Bad, because the brain de-sensitizes to benzodiazepines as it ages, making the effective dose much lower. Cool, because he got hooked up with xanax. Focused on cognitive testing for the detection of lesion or other source of impairment. Can include intelligence testing and assessment of gaps in achievement and aptitude potential. High focus on assessment cognitive or intelligence.

Get access

Grade+
$40 USD/m
Billed monthly
Grade+
Homework Help
Study Guides
Textbook Solutions
Class Notes
Textbook Notes
Booster Class
10 Verified Answers
Class+
$30 USD/m
Billed monthly
Class+
Homework Help
Study Guides
Textbook Solutions
Class Notes
Textbook Notes
Booster Class
7 Verified Answers

Related Documents

PSYC 3290
Final Exam
Study Guide
PSYC 3290 Study Guide - Final Guide: Dsm-5, Cengage Learning, Frontal Lobe
nazariliiii32
PSYC 1002 Lecture Notes - Lecture 17: Person-Centered Therapy, Rational Emotive Behavior Therapy, Fritz Perls
redcrocodile640
PSYC 1002 Lecture Notes - Lecture 8: Aaron T. Beck, Dream Interpretation, Lobotomy
whitebear636